Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Dabigatran or its salts or derivativesPDL

including but not limited to dabigatran etexilate

I DEC / 13
Dabrafenib or its saltsPDL I DEC / 13
DacarbazinePDL I DEC / 13
Daclatasvir or its saltsPDL I OCT / 15
DaclizumabPDL I DEC / 13
Daclizumab betaPDL I FEB / 17
DactinomycinPDL I DEC / 13
Dalfopristin or its saltsPDL I DEC / 13
Dalteparin or its saltsPDL I DEC / 13
Danaparoid or its salts or derivativesPDL I DEC / 13
DanazolPDL I DEC / 13
Danofloxacin or its saltsPDL I DEC / 13
Danthron III SEP / 98
Dantrolene or its saltsPDL I DEC / 13
Dapagliflozin or its derivativesPDL I MAR / 15
Dapiprazole or its saltsPDL I DEC / 13
DaptomycinPDL I DEC / 13
DaratumumabPDL I AUG / 16
Darifenacin or its saltsPDL I DEC / 13
DarunavirPDL I DEC / 13
Dasabuvir or its saltsPDL I MAR / 15
DasatanibPDL I DEC / 13
Daunorubicin or its saltsPDL I DEC / 13
Debrisoquin or its saltsPDL I DEC / 13
DeferasiroxPDL I DEC / 13
Deferiprone or its derivativesPDL I MAR / 15
Deferoxamine or its saltsPDL I DEC / 13
Degarelix or its salts or derivativesPDL I DEC / 13
Dehydrocholic acid and its salts III SEP / 98
Delavirdine or its saltsPDL I DEC / 13
DelorazepamTS I JUN / 02
DenosumabPDL I DEC / 13
Deoxycholic acid or its saltsPDL

when used in an injectable form

I OCT / 15
Deoxycholic acid or its salts.

except when used in an injectable form

III OCT / 15
DeracoxibPDL I DEC / 13
Derquantel or its saltsPDL

for veterinary use

I AUG / 16
Deserpidine or its alkaloids or saltsPDL I DEC / 13
DesfluranePDL I DEC / 13
Desipramine or its saltsPDL I DEC / 13
Desloratadine and its salts and preparations. in products marketed for paediatric use - under 12 years of age III SEP / 05
Desloratadine and its salts and preparations.

in products marketed for adult use - 12 years and older

U SEP / 05
Desmopressin or its saltsPDL I DEC / 13
DesomorphineN I JUN / 02
Desoxyribonuclease [pancreatic dornase] II SEP / 98
Desvenlafaxine or its saltsPDL

including but not limited to desvenlafaxine succinate

I DEC / 13
Detomidine or its saltsPDL I DEC / 13
Dexbrompheniramine and its salts III SEP / 98
Dexchlorpheniramine and its salts III SEP / 98
Dexrazoxane or its saltsPDL I DEC / 13
Dextromethorphan and its salts except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide III AUG / 02
Dextromethorphan and its salts. in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide U AUG / 02
DextromoramideN I JUN / 02
DextropropoxypheneN I JUN / 02
Dextrose sclerosing agents II SEP / 98
Dextrose injection concentrated solutions for parenteral injection I JAN / 03
DiampromideN I JUN / 02
Diazepam and its saltsTS I SEP / 98
Diazoxide or its saltsPDL I DEC / 13
Dibotermin alfaPDL

for veterinary use

I FEB / 14
Dichloroacetic acidPDL I DEC / 13
Diclofenac diethylamine when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing greater than 2.6g of diclofenac diethylamine II AUG / 14
Diclofenac diethylamine.

when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing no more than 2.6g of diclofenac diethylamine

III AUG / 14
Diclofenac diethylamine..

when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

U AUG / 14
Diclofenac or its saltsPDL

including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days

I AUG / 14
Dicyclomine and its salts except for topical use and lozenges II SEP / 98
Didanosine or its salts or derivativesPDL I DEC / 13
DiethylbromacetamidePDL I DEC / 13
Diethylcarbamazine or its saltsPDL I DEC / 13
Diethylpropion and any salt thereofC2 I JUN / 02
Diethylstilbestrol or its salts or derivativesPDL I DEC / 13
DiethylthiambuteneN I JUN / 02
DifenoxinN I JUN / 02
Difloxacin or its salts or derivativesPDL I DEC / 13
Diflunisal or its saltsPDL I DEC / 13
Digestive enzymes from plant sources U SEP / 99
Digoxin immune FabF1 ovine I SEP / 98
DihydrocodeineN I JUN / 02
DihydromorphineN I JUN / 02
Dihydroquinidine and its salts except phenylbarbiturate II SEP / 98
Dihydrostreptomycin and its salts and derivativesF2 I SEP / 98
DihydrotachysterolF1 I SEP / 98
DiiodohydroxyquinF1 except in preparations for topical use on the skin I SEP / 98
Diiodohydroxyquin for topical use on the skin II SEP / 98
Diltiazem and its saltsF1 I SEP / 98
Dimenhydrinate and its salts for parenteral use II SEP / 98
Dimenhydrinate and its salts. for oral or rectal use [Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, dimenhydrinate products should not be located in a self-selection area of the pharmacy]. III APR / 99
DimenoxadolN I JUN / 02
DimepheptanolN I JUN / 02
DimercaprolF1 I SEP / 98
Dimethothiazine III SEP / 98
Dimethyl sulfoxideF1 for veterinary use or when sold for the treatment of interstitial cystitis or scleroderma in humans I DEC / 11
DimethylaminodiphenylbutanonitrileN I JUN / 02
DimethylthiambuteneN I JUN / 02
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
Dinitrophenol or its salts or derivativesPDL I DEC / 13
Dioxaphetyl butyrateN I JUN / 02
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98
Diphenhydramine and its salts and preparations. except for parenteral or topical use III SEP / 98
Diphenhydramine and its salts and preparations.. for topical use in concentrations of greater than 2% II MAY / 06

145 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled